Selective inflammatory effect of systemic fluorouracil in actinic keratosis

Cutis

Volumn 64, Issue 1, 1999, Pages 43-44

  Nabai, Hossein ^a,c   Mohindra, Ramesh ^b   Mehregan, Darius ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST MARY MERCY HOSPITAL   (United States)

^c Marian Professional Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL;

ADENOCARCINOMA; AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COLON TUMOR; HUMAN; KERATOSIS; MALE; OINTMENT; PATHOLOGY; TOPICAL DRUG ADMINISTRATION;

ADENOCARCINOMA; ADMINISTRATION, TOPICAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; FLUOROURACIL; HUMANS; KERATOSIS; MALE; OINTMENTS;

EID: 0033162936     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Falkson G, Schultz EJ: Skin changes in patients treated with 5-fluorouracil. Br J Dermatol 74: 229-236, 1962.
2. Omura EF, Torre D: Inflammation of actinic keratoses due to systemic fluorouracil therapy. JAMA 150-151, 1969.
3. Dillaha CJ, Jansen JT, Bradford AC: Selective cytotoxic effect on topical 5-fluorouracil. Arch Dermatol 88: 247-256, 1963.
4. Sander C, Pfeiffer C, Kligman AM, et al: Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 36: 236-238, 1997.
5. Santi DV, McLenry CS, Sommer H: Mechanism of interaction of thymidylate synthetase with 5-fluourodeoxycidylate Biochemistry 13: 471, 1974.